Researchers investigated the potential association between cutaneous lymphoma and anti-TNFα therapy in a recent study.

News

News
Tuesday, June 27, 2017
Patients requiring injectable medication who are reluctant to begin treatment, may adhere if they are offered alternative treatment regimens, a recent study found.
News
Wednesday, June 14, 2017
Itch intensity in moderate to severe plaque psoriasis can be substantial, and may be on a par with the notoriously itchy skin condition atopic dermatitis, new research suggests.
News
Monday, June 12, 2017
Patients diagnosed with psoriasis and psoriatic arthritis are at an increased risk of osteoporosis, along with osteopenia, ankylosing spondylitis, and pathological fractures, according to a new study.
News
Thursday, June 8, 2017
Patients with moderate to severe plaque psoriasis who were treated with tildrakizumab acheived improved PASI scores, according to a recent study.

Research in Review

Research in Review
Thursday, February 11, 2016
In this excerpt from the recently published book, Practical Psoriasis Management, the authors discuss the use of secukinumab for moderate-to-severe psoriasis.   
Research in Review
Friday, December 18, 2015
A 5-year-old girl presented with a 3-week history of multiple discrete, pink, scaly plaques. The plaques were ovoid, ranged from 0.5 to 3 cm in diameter, and were slightly raised, blanchable, and pruritic.
Research in Review
Monday, June 15, 2015
Research in Review
Tuesday, April 21, 2015
Joel M. Gelfand, MD, MSCE, associate professor of dermatology and epidemiology, University of Pennsylvania Perelman School of Medicine, is co-chair of the Interdisciplinary Autoimmune Summit (IAS). In this interview, Dr. Gelfand fills The Dermatologist readers in on the importance of the IAS meeting, psoriasis research and more.